Wulf GG, Wang RY, Kuehnle I, Weidner D, Marini F, Brenner MK, Andreeff M , Goodell MA
[2] The SURPASS-1 trial showed a mean HbA1c reduction of up to 2.4% with Mounjaro (15 mg) compared to 1.1% with placebo at 52 weeks
You might notice slightly delayed appetite suppression or somewhat reduced effectiveness
Initially marketed by innovator Nordisk as an active pharma ingredient for managing Type 2 diabetes, Semaglutide later became popular as a tool to control obesity
Longevity & Anti-Aging Sleep, cognition, skin protocols
The mechanism of action, the effect on gastric emptying, and the resulting dietary sensitivities are identical between brand-name and compounded formulations